Literature DB >> 19679102

Anandamide increases swelling and reduces calcium sensitivity of mitochondria.

Giuseppina Catanzaro1, Cinzia Rapino, Sergio Oddi, Mauro Maccarrone.   

Abstract

The endocannabinoid anandamide alters mitochondria-dependent signal transduction, thus controlling key cellular events like energy homeostasis and induction of apoptosis. Here, the ability of anandamide to directly affect the integrity of mitochondria was investigated on isolated organelles. We found that anandamide dose-dependently increases mitochondrial swelling, and reduces cytochrome c release induced by calcium ions. The effects of anandamide were independent of its target receptors (e.g., cannabinoid or vanilloid receptors), and were paralleled by decreased membrane potential and increased membrane fluidity. Overall, our data suggest that anandamide can impact mitochondrial physiology, by reducing calcium sensitivity and perturbing membrane properties of these organelles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679102     DOI: 10.1016/j.bbrc.2009.08.037

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria.

Authors:  Namrata Singh; Jana Hroudová; Zdeněk Fišar
Journal:  J Mol Neurosci       Date:  2015-03-29       Impact factor: 3.444

2.  The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria.

Authors:  Patrizia Zaccagnino; Susanna D'Oria; Luigi Luciano Romano; Almerinda Di Venere; Anna Maria Sardanelli; Michele Lorusso
Journal:  J Bioenerg Biomembr       Date:  2012-03-22       Impact factor: 2.945

3.  Cross-reactivity of ryanodine receptors with plasma membrane ion channel modulators.

Authors:  Jake T Neumann; Julio A Copello
Journal:  Mol Pharmacol       Date:  2011-06-10       Impact factor: 4.436

4.  Energetic metabolism and human sperm motility: impact of CB₁ receptor activation.

Authors:  A Barbonetti; M R C Vassallo; D Fortunato; S Francavilla; M Maccarrone; F Francavilla
Journal:  Endocrinology       Date:  2010-10-20       Impact factor: 4.736

Review 5.  Cannabinoid signalling and effects of cannabis on the male reproductive system.

Authors:  Mauro Maccarrone; Cinzia Rapino; Felice Francavilla; Arcangelo Barbonetti
Journal:  Nat Rev Urol       Date:  2020-11-19       Impact factor: 14.432

6.  Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.

Authors:  Laurie Hamtiaux; Laurie Hansoulle; Nicolas Dauguet; Giulio G Muccioli; Bernard Gallez; Didier M Lambert
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

7.  Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats.

Authors:  Olivier Le Bacquer; Jérôme Salles; Fabiana Piscitelli; Phelipe Sanchez; Vincent Martin; Christophe Montaurier; Vincenzo Di Marzo; Stéphane Walrand
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-02       Impact factor: 12.910

8.  Proteomic Shifts Reflecting Oxidative Stress and Reduced Capacity for Protein Synthesis, and Alterations to Mitochondrial Membranes in Neurospora crassa Lacking VDAC.

Authors:  Sabbir R Shuvo; Anna Motnenko; Oleg V Krokhin; Victor Spicer; Deborah A Court
Journal:  Microorganisms       Date:  2022-01-18

Review 9.  Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function.

Authors:  Alistair Nunn; Geoffrey Guy; Jimmy D Bell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

10.  Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development.

Authors:  Johannes Beiersdorf; Zsofia Hevesi; Daniela Calvigioni; Jakob Pyszkowski; Roman Romanov; Edit Szodorai; Gert Lubec; Sally Shirran; Catherine H Botting; Siegfried Kasper; Geoffrey W Guy; Roy Gray; Vincenzo Di Marzo; Tibor Harkany; Erik Keimpema
Journal:  JCI Insight       Date:  2020-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.